Afon Technology, a medtech company in Wales, aims to transform diabetes management with its non-invasive glucose monitoring device, GlucowearTM. The company recently partnered with Sony UK Technology Centre for manufacturing, a key step towards bringing the device to market.
Data reveals that patients with heart disease who come from disadvantaged communities experience more complications after their surgery – including a higher risk of death.
Though the UK’s recommended alcohol limit is under 14 units weekly, researchers still suggest less, as the risk of cardiovascular diseases can still be increased by even moderate amounts.
At the University of Freiburg, scientists have created artificial muscles from natural proteins - less Dr Frankenstein, more future potential for reconstructive medicine or soft robotics.
In Canada, a coalition of organisations are funding £11.6 million (CAD 20 million) into Women RISE - a call for gender and health equality research projects.
Wearable sensors can help detect when heavy drinking consumption can lead to negative consequences, by measuring levels of intoxication through the skin .
